Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy
Current strategies to boost anti-tumor immune response include the use of immune checkpoint inhibitors and bispecific T cell-engaging antibodies. Here the authors describe a versatile antibody immobilization nanoplatform that can be used to deliver different combinations of immunotherapeutics, showi...
Saved in:
Main Authors: | Cheng-Tao Jiang, Kai-Ge Chen, An Liu, Hua Huang, Ya-Nan Fan, Dong-Kun Zhao, Qian-Ni Ye, Hou-Bing Zhang, Cong-Fei Xu, Song Shen, Meng-Hua Xiong, Jin-Zhi Du, Xian-Zhu Yang, Jun Wang |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/df1fd3f94ada4483a1c1ec207bb754dd |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
- Monoclonal antibodies in immunodiagnosis and immunotherapy
-
Beyond HAT Adaptor: TRRAP Liaisons with Sp1-Mediated Transcription
by: Bo-Kun Yin, et al.
Published: (2021) -
Nano-bio interfaces effect of two-dimensional nanomaterials and their applications in cancer immunotherapy
by: Zhongmin Tang, et al.
Published: (2021) -
EUDOGENOUS AND EXOGENOUS IMMUNOMODULATORS
by: Editorial article
Published: (2014) -
EUDOGENOUS AND EXOGENOUS IMMUNOMODULATORS
by: Editorial article
Published: (2014)